By Sarina Isaacs
Shares of Sanara MedTech dropped after the company widened its fourth-quarter loss despite a jump in revenue.
The stock was recently down 11% at $31.77. Shares are off about 12% over the past year.
The Fort Worth, Texas-based company said Tuesday it lost $1.5 million, or 18 cents a share, compared with a loss of $237,000, or three cents a share, in the same quarter a year earlier.
Revenue rose 49% to $26.3 million, primarily driven by sales of soft-tissue products in its surgical segment, said Chief Executive Ron Nixon.
Operating expenses rose by 51% to $24.4 million from $16.1 million in the prior year, including higher overhead and research-and-development costs. Interest expenses more than tripled year over year to $1.29 million from $287,000.
Write to Sarina Isaacs at sarina.isaacs@wsj.com
(END) Dow Jones Newswires
March 25, 2025 11:14 ET (15:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。